Page 18 - Read Online

Page 1000 Gmeiner. Cancer Drug Resist 2019;2:994-1001 I http://dx.doi.org/10.20517/cdr.2019.95

6. Stewart L, Redinbo MR, Qiu X, Hol WG, Champoux JJ. A model for the mechanism of human topoisomerase I. Science 1998;279:1534-41.
7. Staker BL, Hjerrild K, Feese MD, Behnke CA, Burgin AB Jr, et al. The mechanism of topoisomerase I poisoning by a camptothecin
analog. Proc Natl Acad Sci U S A 2002;99:15387-92.
8. Lin CP, Ban Y, Lyu YL, Liu LF. Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at
arrested replication forks. J Biol Chem 2009;284:28084-92.
9. Regairaz M, Zhang YW, Fu H, Agama KK, Tata N, et al. Mus81-mediated DNA cleavage resolves replication forks stalled by
topoisomerase I-DNA complexes. J Cell Biol 2011;195:739-49.
10. Sordet O, Redon CE, Guirouilh-Barbat J, Smith S, Solier S, et al. Ataxia telangiectasia mutated activation by transcription- and
topoisomerase I-induced DNA double-strand breaks. EMBO Rep 2009;10:887-93.
11. Cristini A, Ricci G, Britton S, Salimbeni S, Huang SN, et al. Dual processing of R-loops and topoisomerase I induces transcription-
dependent DNA double-strand breaks. Cell Rep 2019;28:3167-81.e6.
12. Rowinsky EK. Weekly topotecan: an alternative to topotecan’s standard daily x 5 schedule? Oncologist 2002;7:324-30.
13. Pourquier P, Ueng LM, Fertala J, Wang D, Park HJ, et al. Induction of reversible complexes between eukaryotic DNA topoisomerase I
and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine. J Biol Chem 1999;274:8516-23.
14. Daroui P, Desai SD, Li TK, Liu AA, Liu LF. Hydrogen peroxide induces topoisomerase I-mediated DNA damage and cell death. J Biol
Chem 2004;279:14587-94.
15. Pourquier P, Jensen AD, Gong SS, Pommier Y, Rogler CE. Human DNA topoisomerase I-mediated cleavage and recombination of duck
hepatitis B virus DNA in vitro. Nucleic Acids Res 1999;27:1919-25.
16. Pourquier P, Ueng LM, Kohlhagen G, Mazumder A, Gupta M, et al. Effects of uracil incorporation, DNA mismatches, and abasic sites on
cleavage and religation activities of mammalian topoisomerase I. J Biol Chem 1997;272:7792-6.
17. Pourquier P, Pilon AA, Kohlhagen G, Mazumder A, Sharma A, et al. Trapping of mammalian topoisomerase I and recombinations
induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects. J Biol Chem
1997;272:26441-7.
18. Yeh YC, Liu HF, Ellis CA, Lu AL. Mammalian topoisomerase I has base mismatch nicking activity. J Biol Chem 1994;269:15498-504.
19. Pommier Y, Kohlhagen G, Pourquier P, Sayer JM, Kroth H, et al. Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors
of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages. Proc Natl Acad Sci U S A
2000;97:2040-5.
20. Antony S, Theruvathu JA, Brooks PJ, Lesher DT, Redinbo M, et al. Enhancement of camptothecin-induced topoisomerase I cleavage
complexes by the acetaldehyde adduct N2-ethyl-2’-deoxyguanosine. Nucleic Acids Res 2004;32:5685-92.
21. Lesher DT, Pommier Y, Stewart L, Redinbo MR. 8-Oxoguanine rearranges the active site of human topoisomerase I. Proc Natl Acad Sci
U S A 2002;99:12102-7.
22. Galmarini CM, Mackey JR, Dumontet C. Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol 2002;3:415-24.
23. Gmeiner WH, Konerding D, James TL. Effect of cytarabine on the NMR structure of a model okazaki fragment from the SV40 genome.
Biochemistry 1999;38:1166-75.
24. Gmeiner WH, Skradis A, Pon RT, Liu J. Cytarabine-induced destabilization of a model Okazaki fragment. Nucleic Acids Res
1998;26:2359-65.
25. Huang SY, Murai J, Dalla Rosa I, Dexheimer TS, Naumova A, et al. TDP1 repairs nuclear and mitochondrial DNA damage induced by
chain-terminating anticancer and antiviral nucleoside analogs. Nucleic Acids Res 2013;41:7793-803.
26. Bonven BJ, Gocke E, Westergaard O. A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in
Tetrahymena R-chromatin. Cell 1985;41:541-51.
27. Pourquier P, Takebayashi Y, Urasaki Y, Gioffre C, Kohlhagen G, et al. Induction of topoisomerase I cleavage complexes by 1-beta
-D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells. Proc Natl Acad Sci U S A 2000;97:1885-90.
28. Patel AG, Flatten KS, Peterson KL, Beito TG, Schneider PA, et al. Immunodetection of human topoisomerase I-DNA covalent complexes.
Nucleic Acids Res 2016;44:2816-26.
29. Cline SD, Osheroff N. Cytosine arabinoside lesions are position-specific topoisomerase II poisons and stimulate DNA cleavage mediated
by the human type II enzymes. J Biol Chem 1999;274:29740-3.
30. Loegering D, Arlander SJ, Hackbarth J, Vroman BT, Roos-Mattjus P, et al. Rad9 protects cells from topoisomerase poison-induced cell
death. J Biol Chem 2004;279:18641-7.
31. Sousa FG, Matuo R, Tang SW, Rajapakse VN, Luna A, et al. Alterations of DNA repair genes in the NCI-60 cell lines and their predictive
value for anticancer drug activity. DNA Repair (Amst) 2015;28:107-15.
32. Zoppoli G, Regairaz M, Leo E, Reinhold WC, Varma S, et al. Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells
to DNA-damaging agents. Proc Natl Acad Sci U S A 2012;109:15030-5.
33. Murai J, Tang SW, Leo E, Baechler SA, Redon CE, et al. SLFN11 Blocks Stressed Replication Forks Independently of ATR. Mol Cell
2018;69:371-84.e6.
34. Al Abo M, Sasanuma H, Liu X, Rajapakse VN, Huang SY, et al. TDP1 is critical for the repair of DNA breaks induced by sapacitabine, a
nucleoside also targeting ATM- and BRCA-deficient tumors. Mol Cancer Ther 2017;16:2543-51.
35. Mini E, Nobili S, Caciagli B, Landini I, Mazzei T. Cellular pharmacology of gemcitabine. Ann Oncol 2006;17 Suppl 5:v7-12.
36. Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W. Action of 2’,2’-difluorodeoxycytidine on DNA synthesis. Cancer Res
1991;51:6110-7.
37. Konerding D, James TL, Trump E, Soto AM, Marky LA, et al. NMR structure of a gemcitabine-substituted model Okazaki fragment.